According to Fact.MR’s recently collated research report, a spectacular growth has been envisaged for the global dual chamber prefilled syringes market in the forecast period (2017-2026). Worldwide sales of dual chamber prefilled syringes are poised to bring in approximately US$ 3,300 Mn revenues by 2026-end.
Request for the Report Summary: https://www.factmr.com/report/486/dual-chamber-prefilled-syringes-market
There has been an incessant requirement for reconstituting the lyophilized drugs during their administration, along with growing necessity of tackling potential compliance and safety issues associated with the reconstitution. This has further led to the development of syringes that are capable of curtailing number of steps required for the reconstitution of drugs and making them available for injection. Dual chamber prefilled syringes are the most efficient solution to cater this requirement, as they enable immediate reconstitution within the syringe just prior to injection.
Dual chamber prefilled syringes seek widespread utilization in storing biological substances and active pharmaceutical components, which cannot retain their stability for extended duration. These devices enable elimination of drug loss through maintenance of the drugs’ sterility prior to injection. Advancements in technology have resulted into improvements in the arrangement of liquid components in the syringes and injectors, while attracting more patients in opting for these efficient & safe syringes.
Request for the Sample of the Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=486
Lyophilized drugs have represented a robust penetration worldwide in the recent past. Lyophilized drugs account for largest share of all reconstitution-requiring injectable/infusible drugs. As a large number of injectable/infusible drugs have been developed for self-administration, special challenges are incurred for the drug developers. However, dual chamber prefilled syringes, which are particularly designed for simplifying reconstitution devoid of patient handling of diluent or drug, have become the mainstay option for delivering these drugs, meanwhile curtailing challenges faced by developers. With lyophilized drugs witnessing proliferated penetration, demand for dual chamber prefilled syringes will gain a significant upsurge in the foreseeable future.
With trends of surging demand for self-injection syringes, and the development of advanced dual chamber prefilled syringes, major players in the market have directed their concentration toward product portfolio expansion. In this rapidly evolving and highly competitive market, several players are emphasizing on essentiality of the up-to-date information, in a bid to monitor their performance and make critical decisions apropos to profitability & growth. Few market players are also focusing on improvements in design of the dual chamber prefilled syringes in order to enhance the stability as well as safety of various sensitive drugs.
Request for Report Methodology: https://www.factmr.com/connectus/sample?flag=RM&rep_id=486
Key players actively underpinning the market growth, as profiled by Fact.MR’s report, include Pfizer Inc., Amgen Inc., Boehringer Ingelheim GmbH, Nipro Corporation, Vetter Pharma-Fertigung GmbH & Co. KG, Gerresheimer AG, Ypsomed Holding AG, West Pharmaceutical Services, Inc., Schott AG, Otsuka America Pharmaceutical, Inc., Credence MedSystems, Inc., Catalent, Inc., and Bespak Europe Ltd.
Fact.MR’s methodology is robust and comprehensive. We employ a range of tools and assets to develop an all-encompassing coverage of a range of industries. We compile data points at local, country, regional, and global level – our approach to capturing the finest nuances, without losing sight of the bigger picture helps us in developing accurate and reliable forecasts and estimates.
Fact.MR has a standard set of guidelines and standards that help maintain a level of consistency across all of our research offerings. The standardization includes step-by-step documentation of the methodologies and guidelines on the sources that are to be used for incorporation of objective and accurate data.
The standardization also involves use of industry-wide analytical tools, and rigorous quality checks to validate market forecasts and sizes. Our unwavering focus on standardization ensures that clients receive the same quality of research and analysis that Fact.MR is known for.
11140 Rockville Pike
Rockville, MD 20852